Antibody discovery, development, and optimization

End-to-end antibody discovery from the lab that has done it 3,000 times.

Thirty-five years. One team from immunization to optimized lead. B cell Select® finds functional antibodies early; AI-enabled analysis informs every candidate decision.

Request a strategy session

Built around your target.

One multidisciplinary team stays with your program from design through molecule delivery, with direct access to the scientists doing the work. We surface risk early, adapt the plan as the biology dictates, and hand you candidates with the evidence behind every decision. Your success is our success.
Drug Discover shift in biologics, construction of a square tower

The lab generates the data. The AI reads it. You get the decision.

Our wet lab runs the discovery. Our scientists use LensAI™ analysis to rank developability and immunogenicity risk before it costs a wet-lab cycle. HYFT® Technology, which reasons over the patterns evolution has conserved, links every candidate to 25B+ known biological relationships. Every prediction is confirmed at the bench before it reaches you.

What we make.

Therapeutic antibodies. Anti-drug and anti-idiotype reagents. Diagnostic and research antibodies. Engineered proteins. Peptide therapeutics and vaccine antigens. Rabbit, chicken, camelid, and mouse repertoires; IgG, bispecific, VHH, scFv, Fab, and fusion formats.

How we discover.

B cell Select®, our memory B cell platform, screens for function before affinity and recovers the native heavy and light chain pair. Hybridoma, yeast display, and B cell Llama™ VHH discovery when the target calls for them. LensAI™ analysis on every hit.

952
Therapeutic Antibodies +
Anti-drug and Anti-idiotype Antibodies +
Diagnostic and Research Antibodies +
Advanced Lab Research +
LensAI™ Analysis +

What we make.

Therapeutic antibodies. Anti-drug and anti-idiotype reagents. Diagnostic and research antibodies. Engineered proteins. Peptide therapeutics and vaccine antigens. Rabbit, chicken, camelid, and mouse repertoires; IgG, bispecific, VHH, scFv, Fab, and fusion formats.

Therapeutic Antibodies +

Therapeutic Antibodies

Transformative workflows driving discovery success.

Read more
Anti-drug and Anti-idiotype Antibodies +

Anti-drug and
Anti-idiotype Antibodies

High success. High reliability. High client retention.

Read more
Diagnostic and Research Antibodies +

Diagnostic and Research Antibodies

Performance and scale for precision detection.

Read more
952

How we discover.

B cell Select®, our memory B cell platform, screens for function before affinity and recovers the native heavy and light chain pair. Hybridoma, yeast display, and B cell Llama™ VHH discovery when the target calls for them. LensAI™ analysis on every hit.

Advanced Lab Research +

Advanced Lab Research

Demonstrated success driving diverse discovery breakthroughs.

Read more
LensAI™ Analysis +

LensAI™ Analysis

Target analysis, candidate ranking, and lead optimization on every hit, confirmed at the bench.

Read more

Science. Technology. Rigor.

35+ years

Expertise matters

Thirty-five years of antibody discovery; 3,000+ completed programs; used by 19 of the top 20 global pharma.

3X
faster

Speed matters

Up to 3X faster from data to discovery.

Early de-risking

Risk matters

Developability and immunogenicity assessed at hit selection and confirmed at the bench, before a candidate reaches you.

>98%
success rate

Success matters

Greater than 98% antibody discovery success* with B cell Select®. 20+ publicly disclosed client antibodies have advanced from our lab into clinical development; publicly disclosed programs only, additional client antibodies have advanced under partner confidentiality.

* “Success” refers to meeting predefined discovery criteria, not clinical or therapeutic outcomes. Results may vary.

Tell us about your target.

A scientist, not a sales rep, replies within two business days.

Case Studies

See validated insights that redefine workflows and advance discovery

See case studies

Scientific Posters

Discover how MindWalk powers smarter paths from concept to clinic.

See posters

Blogs

Explore the latest ideas reshaping the future of discovery.

Read the blog

Spotlight

CaseXCase™: LensAI case study series

A collection of the latest results highlighting how new approaches are shaping modern discovery.

See the case studies
Drug Discovery Spotlight